4//SEC Filing
Molho Davide 4
Accession 0001127602-18-023565
CIK 0001100682other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 8:37 AM ET
Size
9.1 KB
Accession
0001127602-18-023565
Insider Transaction Report
Form 4
Molho Davide
Corporate Executive VP
Transactions
- Sale
Common Stock
2018-07-17$120.00/sh−11,126$1,335,120→ 33,679 total - Exercise/Conversion
Stock Options (Right to Buy)
2018-07-17−6,165→ 6,165 totalExercise: $76.67From: 2016-02-27Exp: 2020-02-27→ Common Stock (6,165 underlying) - Exercise/Conversion
Common Stock
2018-07-17$76.67/sh+6,165$472,671→ 44,805 total
Holdings
- 40,748(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This sale occurred pursuant to a 10b5-1 Trading Plan.
- [F2]On 3/08/2018: 3,514 shares were transferred from Direct Holdings to the Revocable Trust. On 6/05/2018: 21,485 shares were transferred from the Revocable Trust to Direct Holdings.
- [F3]On 3/08/2018: 3,514 shares were transferred from Direct Holdings to the Revocable Trust. On 6/05/2018: 21,485 shares were transferred from the Revocable Trust to Direct Holdings.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL INC
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001507332
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 8:37 AM ET
- Size
- 9.1 KB